Literature DB >> 24347665

Inflammation and mechanical stretch promote aortic stiffening in hypertension through activation of p38 mitogen-activated protein kinase.

Jing Wu1, Salim R Thabet, Annet Kirabo, Daniel W Trott, Mohamed A Saleh, Liang Xiao, Meena S Madhur, Wei Chen, David G Harrison.   

Abstract

RATIONALE: Aortic stiffening commonly occurs in hypertension and further elevates systolic pressure. Hypertension is also associated with vascular inflammation and increased mechanical stretch. The interplay between inflammation, mechanical stretch, and aortic stiffening in hypertension remains undefined.
OBJECTIVE: Our aim was to determine the role of inflammation and mechanical stretch in aortic stiffening. METHODS AND
RESULTS: Chronic angiotensin II infusion caused marked aortic adventitial collagen deposition, as quantified by Masson trichrome blue staining and biochemically by hydroxyproline content, in wild-type but not in recombination activating gene-1-deficient mice. Aortic compliance, defined by ex vivo measurements of stress-strain curves, was reduced by chronic angiotensin II infusion in wild-type mice (P<0.01) but not in recombination activating gene-1-deficient mice (P<0.05). Adoptive transfer of T-cells to recombination activating gene-1-deficient mice restored aortic collagen deposition and stiffness to values observed in wild-type mice. Mice lacking the T-cell-derived cytokine interleukin 17a were also protected against aortic stiffening. In additional studies, we found that blood pressure normalization by treatment with hydralazine and hydrochlorothiazide prevented angiotensin II-induced vascular T-cell infiltration, aortic stiffening, and collagen deposition. Finally, we found that mechanical stretch induces the expression of collagen 1α1, 3α1, and 5a1 in cultured aortic fibroblasts in a p38 mitogen-activated protein kinase-dependent fashion, and that inhibition of p38 prevented angiotensin II-induced aortic stiffening in vivo. Interleukin 17a also induced collagen 3a1 expression via the activation of p38 mitogen-activated protein kinase.
CONCLUSIONS: Our data define a pathway in which inflammation and mechanical stretch lead to vascular inflammation that promotes collagen deposition. The resultant increase in aortic stiffness likely further worsens systolic hypertension and its attendant end-organ damage.

Entities:  

Keywords:  inflammation

Mesh:

Substances:

Year:  2013        PMID: 24347665      PMCID: PMC4186716          DOI: 10.1161/CIRCRESAHA.114.302157

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  50 in total

1.  Effect of an acute mechanical stimulus on aortic structure in the transverse aortic constriction mouse model.

Authors:  Jing Chen; Jian Wu; Lei Li; Yun-Zeng Zou; Ding-Liang Zhu; Ping-Jin Gao
Journal:  Clin Exp Pharmacol Physiol       Date:  2011-09       Impact factor: 2.557

2.  Activation of vascular p38MAPK by mechanical stretch is independent of c-Src and NADPH oxidase: influence of hypertension and angiotensin II.

Authors:  Tamara M Paravicini; Augusto C Montezano; Hiba Yusuf; Rhian M Touyz
Journal:  J Am Soc Hypertens       Date:  2012-02-15

3.  High-throughput quantification of hydroxyproline for determination of collagen.

Authors:  Kathleen Hofman; Bronwyn Hall; Helen Cleaver; Susan Marshall
Journal:  Anal Biochem       Date:  2011-06-22       Impact factor: 3.365

4.  Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension.

Authors:  Paul J Marvar; Salim R Thabet; Tomasz J Guzik; Heinrich E Lob; Louise A McCann; Connie Weyand; Frank J Gordon; David G Harrison
Journal:  Circ Res       Date:  2010-06-17       Impact factor: 17.367

5.  Urinary miR-21, miR-29, and miR-93: novel biomarkers of fibrosis.

Authors:  Gang Wang; Bonnie Ching-Ha Kwan; Fernand Mac-Moune Lai; Kai-Ming Chow; Philip Kam-Tao Li; Cheuk-Chun Szeto
Journal:  Am J Nephrol       Date:  2012-10-27       Impact factor: 3.754

6.  Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage.

Authors:  Lajos Markó; Heda Kvakan; Joon-Keun Park; Fatimunnisa Qadri; Bastian Spallek; Katrina J Binger; Edward P Bowman; Markus Kleinewietfeld; Verena Fokuhl; Ralf Dechend; Dominik N Müller
Journal:  Hypertension       Date:  2012-10-29       Impact factor: 10.190

7.  Aortic stiffness, blood pressure progression, and incident hypertension.

Authors:  Bernhard M Kaess; Jian Rong; Martin G Larson; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Emelia J Benjamin; Ramachandran S Vasan; Gary F Mitchell
Journal:  JAMA       Date:  2012-09-05       Impact factor: 56.272

8.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

9.  p38/MKP-1-regulated AKT coordinates macrophage transitions and resolution of inflammation during tissue repair.

Authors:  Eusebio Perdiguero; Pedro Sousa-Victor; Vanessa Ruiz-Bonilla; Mercè Jardí; Carme Caelles; Antonio L Serrano; Pura Muñoz-Cánoves
Journal:  J Cell Biol       Date:  2011-10-10       Impact factor: 10.539

10.  Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.

Authors:  Kaisa M Mäki-Petäjä; Maysoon Elkhawad; Joseph Cheriyan; Francis R Joshi; Andrew J K Ostör; Frances C Hall; James H F Rudd; Ian B Wilkinson
Journal:  Circulation       Date:  2012-10-24       Impact factor: 29.690

View more
  114 in total

Review 1.  Aging, arterial stiffness, and hypertension.

Authors:  Zhongjie Sun
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Origin of Matrix-Producing Cells That Contribute to Aortic Fibrosis in Hypertension.

Authors:  Jing Wu; Kim Ramil C Montaniel; Mohamed A Saleh; Liang Xiao; Wei Chen; Gary K Owens; Jay D Humphrey; Mark W Majesky; David T Paik; Antonis K Hatzopoulos; Meena S Madhur; David G Harrison
Journal:  Hypertension       Date:  2015-12-22       Impact factor: 10.190

3.  Pulmonary Arterial Stiffness: Toward a New Paradigm in Pulmonary Arterial Hypertension Pathophysiology and Assessment.

Authors:  Michal Schäfer; Cynthia Myers; R Dale Brown; Maria G Frid; Wei Tan; Kendall Hunter; Kurt R Stenmark
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

Review 4.  Dual opposing roles of adaptive immunity in hypertension.

Authors:  Noureddine Idris-Khodja; Muhammad Oneeb Rehman Mian; Pierre Paradis; Ernesto L Schiffrin
Journal:  Eur Heart J       Date:  2014-03-30       Impact factor: 29.983

Review 5.  Immune Mechanisms in Arterial Hypertension.

Authors:  Ulrich Wenzel; Jan Eric Turner; Christian Krebs; Christian Kurts; David G Harrison; Heimo Ehmke
Journal:  J Am Soc Nephrol       Date:  2015-08-28       Impact factor: 10.121

6.  Modeling mechano-driven and immuno-mediated aortic maladaptation in hypertension.

Authors:  Marcos Latorre; Jay D Humphrey
Journal:  Biomech Model Mechanobiol       Date:  2018-06-07

7.  Compromised mechanical homeostasis in arterial aging and associated cardiovascular consequences.

Authors:  J Ferruzzi; D Madziva; A W Caulk; G Tellides; J D Humphrey
Journal:  Biomech Model Mechanobiol       Date:  2018-05-12

Review 8.  Inflammation, immunity, and hypertensive end-organ damage.

Authors:  William G McMaster; Annet Kirabo; Meena S Madhur; David G Harrison
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 9.  Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension.

Authors:  Liang Xiao; David M Patrick; Luul A Aden; Annet Kirabo
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-09-29       Impact factor: 3.072

10.  Adaptive immunity and IL-17A are not involved in the progression of chronic kidney disease after 5/6 nephrectomy in mice.

Authors:  Alva Rosendahl; Reza Kabiri; Marlies Bode; Anna Cai; Stefanie Klinge; Heimo Ehmke; Hans-Willi Mittrücker; Ulrich O Wenzel
Journal:  Br J Pharmacol       Date:  2018-12-18       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.